<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29450" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Staphylococcal Pneumonia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Clark</surname>
            <given-names>Shane B.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hicks</surname>
            <given-names>Matthew A.</given-names>
          </name>
          <aff>McLaren Greater Lansing/Michigan St.</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shane Clark declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Hicks declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29450.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Staphylococcal pneumonia is a disease process that requires prompt diagnosis, as sequelae can lead to complications such as severe necrotizing pneumonia, bacteremia, or sepsis with or without shock. Staphylococcal pneumonia can be seen in a post-viral state. This activity reviews the evaluation and treatment of staphylococcal pneumonia and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the typical presentation of a patient with staphylococcal pneumonia.</p></list-item><list-item><p>Explain the common physical exam findings with staphylococcal pneumonia.</p></list-item><list-item><p>Summarize the treatment of staphylococcal pneumonia.</p></list-item><list-item><p>Explain the importance of improving care coordination amongst the interprofessional team to enhance the delivery of care for patients with staphylococcal pneumonia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29450&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29450">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29450.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Staphylococcus aureus</italic> (<italic toggle="yes">S. aureus</italic>) is a pathogen that has been published in the literature since the 1800s. At that time, it was better recognized as a cause of sepsis and abscess formation. More than a century after the first descriptions of <italic toggle="yes">Staphylococcus</italic> were written, we now understand it to be at the forefront of many disease processes, one of which is staphylococcal pneumonia. <italic toggle="yes">Staphylococcus</italic> remains at the forefront of infectious disease due to its enzyme production of protease, lipase, hyaluronidase, as well as its ability to make penicillin binding protein 2A (PBP-2A) through the mecA gene, leading to the staphylococcal strain known as methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA). This escalates its ability to become resistant to previous and current antibiotic therapies.<xref ref-type="bibr" rid="article-29450.r1">[1]</xref></p>
      </sec>
      <sec id="article-29450.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Community-acquired staphylococcal pneumonia is usually seen in patients that are recovering from influenza. The infection is seen in a bimodal distribution, with the younger and elderly populations being more at risk. It should be noted that P<italic toggle="yes">neumococcus</italic> is still the leading cause of post-viral pneumonia in this population.<xref ref-type="bibr" rid="article-29450.r2">[2]</xref>&#x000a0;Individuals may also be colonized with <italic toggle="yes">S. aureus</italic> on the skin or in nares, and this can also lead to pulmonary infections and is seen in both the community and in the hospital setting. Another notable etiology of <italic toggle="yes">S. aureus</italic> pneumonia is seen in patients who abuse intravenous drugs. Due to contamination of the skin or equipment, IV drug abuse can lead to multiple systemic infections from <italic toggle="yes">S. aureus</italic> such as tricuspid valve endocarditis, bacteremia, and septic emboli to the lungs.<xref ref-type="bibr" rid="article-29450.r3">[3]</xref></p>
      </sec>
      <sec id="article-29450.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>When describing <italic toggle="yes">S. aureus</italic>, it is crucial to delineate methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA) from methicillin-susceptible <italic toggle="yes">Staphylococcus aureus</italic> (MSSA) as this will determine the treatment strategies for these patients. A large, international multicenter study of hospitalized patients with community-acquired pneumonia (CAP) found that 3% of patients developed CAP secondary to MRSA. This had varying prevalence depending on the residency and location of the patient. Fifty-one percent of the <italic toggle="yes">S. aureus</italic> isolates were found to be secondary to MRSA, and 49% were secondary to MSSA.<xref ref-type="bibr" rid="article-29450.r4">[4]</xref>&#x000a0;Another study of inpatients who were hospitalized for CAP in the United States showed that 1.7% were secondary to <italic toggle="yes">S. aureus, </italic>and&#x000a0;of these, 0.7% were secondary to MRSA, and 1% were secondary to MSSA.<xref ref-type="bibr" rid="article-29450.r5">[5]</xref></p>
      </sec>
      <sec id="article-29450.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Bacteria and viruses are part of the healthy microbiome of the lower respiratory tract, and the majority of the microbiome of the alveoli are composed of anaerobic flora and microaerophilic streptococci. One mechanism of the development of pneumonia is the replication and multiplication of these organisms. Another mechanism is a breakdown of the host's innate immune system, which can lead to overwhelming multiplication of the normal healthy lower respiratory tract flora.<xref ref-type="bibr" rid="article-29450.r6">[6]</xref>&#x000a0;It is known that tobacco and alcohol use can alter the host defense and predispose to the development of pneumonia. More specific to staphylococcal pneumonia, microaspiration of staph species in the nares can lead to the development of staphylococcal pneumonia. Hematogenous spread from staphylococcal bacteremia can also develop into staphylococcal pneumonia, and this can be seen in staphylococcal endocarditis.</p>
      </sec>
      <sec id="article-29450.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p><italic toggle="yes">S. aureus</italic> infection can preclude patients to a wide range of infectious processes. Therefore, a thorough multisystem history and physical should be performed. When evaluating the need for hospitalization of the patient, care should be taken to assess the onset of symptoms, duration of symptoms, as well as associative symptoms of fever, chills, dyspnea, or productive cough. Eighty percent of patients with pneumonia can be febrile. However, this finding is less reliable in the elderly. Evaluation for sick contacts, recent travel, ongoing or recent infection with influenza can also help delineate those who may have a higher predisposition to developing <italic toggle="yes">S. aureus</italic> pneumonia. Employment status and recent hospitalizations can be ascertained to raise clinical suspicion for colonization with <italic toggle="yes">S. aureus</italic>, such as healthcare workers.</p>
        <p>In the appropriate clinical scenario, evaluation for IV drug use should be ascertained as tricuspid valve endocarditis from IV drug use can lead to septic emboli to the lungs and cause <italic toggle="yes">S. aureus</italic> pneumonia. Physical exam should include a complete multisystem evaluation, but the focus should be given to the cardiopulmonary examination to assess for signs of valvular murmur, respiratory distress, tachypnea, or inspiratory crackles in a lobar pattern. Percussion and tactile fremitus can also be utilized if there is a concern for pleural effusion. Unfortunately, there is no specific constellation of history and physical exam findings that can effectively guarantee with certainty a diagnosis of pneumonia,&#x000a0;but the above findings do further the clinical suspicion of this disease process.<xref ref-type="bibr" rid="article-29450.r7">[7]</xref></p>
      </sec>
      <sec id="article-29450.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Initial evaluation for staphylococcal pneumonia starts with the same foundational workup for those suspected of having any etiology of CAP. A complete blood count (CBC) will likely show leukocytosis with a neutrophilic predominance. The gold standard for diagnosing pneumonia with the appropriate clinical suspicion is the presence of infiltrate on a chest radiograph.<xref ref-type="bibr" rid="article-29450.r8">[8]</xref>&#x000a0;The infiltrate on a chest radiograph can show lobar infiltrate or in severe patients can show cavitary lesions and empyema. If the clinical syndrome supports the diagnosis of pneumonia, but the chest radiograph does not reveal pathology, a computed tomography (CT) scan can be performed to further evaluate for pathology in the lungs.</p>
        <p>Findings on CT scan may show a developing lobar infiltrate or cavitary lesion that chest radiograph may not reveal.<xref ref-type="bibr" rid="article-29450.r9">[9]</xref>&#x000a0;A sputum sample can be obtained,&#x000a0;but&#x000a0;a 2005 study noted that only 17% of the study population were able to produce an adequate sample. However, if the patient can produce an adequate sample, 82% were found to be diagnostic and could be used to guide antibiotic therapy.<xref ref-type="bibr" rid="article-29450.r10">[10]</xref>&#x000a0;An MRSA swab may also be utilized to assess the patient's colonization status for MRSA and, therefore, further the suspicion of this process. A procalcitonin level can also be drawn at the time of treatment in order to guide antibiotic efficacy and aid in antibiotic stewardship.<xref ref-type="bibr" rid="article-29450.r11">[11]</xref></p>
      </sec>
      <sec id="article-29450.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment for staphylococcal pneumonia depends on if this process is categorized into either MRSA or MSSA. If MRSA is suspected or confirmed, either vancomycin or linezolid should be initiated at the start of treatment and be promptly discontinued if MRSA is ruled out. Both vancomycin and linezolid have similar efficacy, and selection should be based on patient tolerance, antibiotic allergy profile, renal function, drug interaction, and intravenous access. As linezolid is systemically bioavailable in its oral form, this is preferred if there is an issue with intravenous access. Vancomycin is preferred if the patient is cytopenic or taking selective serotonin reuptake inhibitors (SSRIs).<xref ref-type="bibr" rid="article-29450.r12">[12]</xref><xref ref-type="bibr" rid="article-29450.r13">[13]</xref>&#x000a0;Ceftaroline can be used if vancomycin or linezolid are contraindicated; however, it should be known that it is not FDA approved for hospital-acquired pneumonia or ventilator-associated pneumonia. Clindamycin is also an alternative, but&#x000a0;it is also less efficacious in hospital-acquired and ventilator-associated pneumonia.<xref ref-type="bibr" rid="article-29450.r14">[14]</xref>&#x000a0;</p>
        <p>If culture results grow MSSA and rule out other causes of pneumonia, then therapy can be de-escalated to nafcillin, oxacillin, or cefazolin.<xref ref-type="bibr" rid="article-29450.r15">[15]</xref>&#x000a0;Supportive measures for staphylococcal pneumonia include bronchodilation to help those with underlying lung diseases such as asthma or chronic obstructive pulmonary disease (COPD). Supplemental oxygenation may also be needed due to the restrictive lung disease caused by the pneumonia disease process. This can begin with a nasal cannula. However, if the disease process is severe enough, then mechanical ventilation may be necessary.</p>
      </sec>
      <sec id="article-29450.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>As the clinical presentation for pneumonia and, therefore, staphylococcal pneumonia is broad and nonspecific, so is the differential for this process. Differential diagnosis may include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pneumonia secondary to:</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Streptococcal pneumonia&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Nontypeable <italic toggle="yes">Haemophilus influenza</italic>&#x000a0;</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">Mycoplasma</italic> pneumonia&#x000a0;</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">Chlamydia</italic> pneumonia&#x000a0;</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">Legionella</italic>&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Gram-negative bacilli&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Group A <italic toggle="yes">Streptococcus</italic>&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Anaerobic infection&#x000a0;</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">Mycoplasma tuberculosis</italic>&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Viral infection&#x000a0;</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Pulmonary edema secondary to congestive heart failure&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pulmonary hemorrhage&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Atelectasis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pneumonitis from aspiration or chemical exposure&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Interstitial lung disease&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Drug reaction&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pulmonary embolism</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29450.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis of staphylococcal pneumonia is very much dependent on the patient's comorbid conditions, underlying lung disease, and sequelae of this disease process. Prognosis is more guarded if the patient becomes bacteremic, and this further alludes to the importance of astute clinical suspicion and appropriate antibiotic intervention.</p>
      </sec>
      <sec id="article-29450.s11" sec-type="Complications">
        <title>Complications</title>
        <p>A significant complication of staphylococcal pneumonia is the development of severe necrotizing pneumonia. This can be seen in community associated-MRSA (CA-MRSA).<xref ref-type="bibr" rid="article-29450.r16">[16]</xref>&#x000a0;If this is of clinical concern, then a chest CT may be warranted to help further assess for this pathology. It should be noted that a chest CT should not be used in the initial diagnosis of pneumonia, and that chest x-ray should be ordered first as a foundational approach to the initial evaluation of pneumonia. Staphylococcal pneumonia may also lead to complications such as sepsis, septic shock, bacteremia, and respiratory failure leading to invasive mechanical ventilation.</p>
      </sec>
      <sec id="article-29450.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated on the presentation of CAP in the outpatient setting, as this could lead to a faster diagnosis of CAP and possibly staphylococcal pneumonia in the appropriate clinical scenario. This is important for patients to be educated on, as prompt antibiotic therapy can help resolve this infectious process before sequelae such as sepsis, bacteremia, or respiratory failure occur.</p>
      </sec>
      <sec id="article-29450.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Clinicians&#x000a0;need to have an interprofessional team approach to the diagnosis and treatment of these patients. There should&#x000a0;be a broad clinical suspicion with this and any presentation of patients with pneumonia. Nursing staff should also have a broad suspicion as they are foundational to patient care and help add information that the patient may not have alluded to during the initial encounter. Pharmacy staff should also be utilized to their fullest potential as antibiotic therapy and stewardship are essential to practice to help not only treat this disease process but also prevent antibiotic resistance in the future.</p>
      </sec>
      <sec id="article-29450.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29450&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29450">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/lung-disease-respiratory-health/staphylococcal-pneumonia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29450">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29450/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29450">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-29450.s15">
        <fig id="article-29450.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Healthy Lung and Q Fever Pneumatic Lung, Chest X-ray. X-ray A represents a normal healthy lung; X-ray B represents a lung with Q fever pneumonia. Hehkuviini, Public Domain, via <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/wiki/File:Pneumonia_x-ray.jpg">Wikimedia Commons</ext-link>.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="358px-Pneumonia_x-ray" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-29450.s16">
        <fig id="article-29450.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Bilateral Pneumonia, Computed Tomography Scan. Bilateral pneumonia with abscesses, effusions, and cavers in an adult male. Christaras A, Public Domain, via Wikimedia Commons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/2.5/deed.en">CC by 2.5</ext-link>).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CT_chest_in_pneumonia_with_abscesses_caverns_and_effusions_d0" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-29450.s17">
        <title>References</title>
        <ref id="article-29450.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lowy</surname>
                <given-names>FD</given-names>
              </name>
            </person-group>
            <article-title>Staphylococcus aureus infections.</article-title>
            <source>N Engl J Med</source>
            <year>1998</year>
            <month>Aug</month>
            <day>20</day>
            <volume>339</volume>
            <issue>8</issue>
            <fpage>520</fpage>
            <page-range>520-32</page-range>
            <pub-id pub-id-type="pmid">9709046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Francis</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Doherty</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lopatin</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hansel</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Perl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ticehurst</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Nuermberger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes.</article-title>
            <source>Clin Infect Dis</source>
            <year>2005</year>
            <month>Jan</month>
            <day>01</day>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>100</fpage>
            <page-range>100-7</page-range>
            <pub-id pub-id-type="pmid">15614698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hind</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications.</article-title>
            <source>Thorax</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>11</issue>
            <fpage>891</fpage>
            <page-range>891-8</page-range>
            <pub-id pub-id-type="pmid">2256022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aliberti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reyes</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Faverio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sotgiu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Soni</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>MI</given-names>
              </name>
              <collab>GLIMP investigators</collab>
            </person-group>
            <article-title>Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>12</issue>
            <fpage>1364</fpage>
            <page-range>1364-1376</page-range>
            <pub-id pub-id-type="pmid">27593581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Self</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Wunderink</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Balk</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Fakhran</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Chappell</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Casimir</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Courtney</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Trabue</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Waterer</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Bramley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Magill</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Grijalva</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Aug</month>
            <day>01</day>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>300</fpage>
            <page-range>300-9</page-range>
            <pub-id pub-id-type="pmid">27161775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strieter</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Belperio</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Host innate defenses in the lung: the role of cytokines.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>193</fpage>
            <page-range>193-8</page-range>
            <pub-id pub-id-type="pmid">12821807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Metlay</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>WN</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination.</article-title>
            <source>JAMA</source>
            <year>1997</year>
            <month>Nov</month>
            <day>05</day>
            <volume>278</volume>
            <issue>17</issue>
            <fpage>1440</fpage>
            <page-range>1440-5</page-range>
            <pub-id pub-id-type="pmid">9356004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandell</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Wunderink</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Anzueto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Dowell</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>File</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Musher</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Niederman</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Whitney</surname>
                <given-names>CG</given-names>
              </name>
              <collab>Infectious Diseases Society of America</collab>
              <collab>American Thoracic Society</collab>
            </person-group>
            <article-title>Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.</article-title>
            <source>Clin Infect Dis</source>
            <year>2007</year>
            <month>Mar</month>
            <day>01</day>
            <volume>44 Suppl 2</volume>
            <issue>Suppl 2</issue>
            <fpage>S27</fpage>
            <page-range>S27-72</page-range>
            <pub-id pub-id-type="pmid">17278083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Syrj&#x000e4;l&#x000e4;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Broas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suramo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ojala</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>L&#x000e4;hde</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>High-resolution computed tomography for the diagnosis of community-acquired pneumonia.</article-title>
            <source>Clin Infect Dis</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>358</fpage>
            <page-range>358-63</page-range>
            <pub-id pub-id-type="pmid">9709887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Eerden</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Vlaspolder</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>de Graaff</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Groot</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Boersma</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>241</fpage>
            <page-range>241-9</page-range>
            <pub-id pub-id-type="pmid">15902529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christ-Crain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jaccard-Stolz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bingisser</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gencay</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Tamm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.</article-title>
            <source>Lancet</source>
            <year>2004</year>
            <month>Feb</month>
            <day>21</day>
            <volume>363</volume>
            <issue>9409</issue>
            <fpage>600</fpage>
            <page-range>600-7</page-range>
            <pub-id pub-id-type="pmid">14987884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>32</volume>
            <issue>9</issue>
            <fpage>1121</fpage>
            <page-range>1121-8</page-range>
            <pub-id pub-id-type="pmid">23568605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zou</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Xing</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.</article-title>
            <source>Eur J Clin Pharmacol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-15</page-range>
            <pub-id pub-id-type="pmid">25355172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bayer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cosgrove</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Daum</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Fridkin</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Gorwitz</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Karchmer</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>J Rybak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Talan</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Chambers</surname>
                <given-names>HF</given-names>
              </name>
              <collab>Infectious Diseases Society of America</collab>
            </person-group>
            <article-title>Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.</article-title>
            <source>Clin Infect Dis</source>
            <year>2011</year>
            <month>Feb</month>
            <day>01</day>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>e18</fpage>
            <page-range>e18-55</page-range>
            <pub-id pub-id-type="pmid">21208910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalil</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Metersky</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Klompas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Muscedere</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Carratal&#x000e0;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>El Solh</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ewig</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fey</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>File</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Waterer</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Cruse</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Brozek</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Sep</month>
            <day>01</day>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>e61</fpage>
            <page-range>e61-e111</page-range>
            <pub-id pub-id-type="pmid">27418577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29450.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gillet</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Issartel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vanhems</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fournet</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lina</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vandenesch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pi&#x000e9;mont</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Brousse</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Floret</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Etienne</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.</article-title>
            <source>Lancet</source>
            <year>2002</year>
            <month>Mar</month>
            <day>02</day>
            <volume>359</volume>
            <issue>9308</issue>
            <fpage>753</fpage>
            <page-range>753-9</page-range>
            <pub-id pub-id-type="pmid">11888586</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
